264 related articles for article (PubMed ID: 30593185)
41. Nonremission and Recurrent Tumor-Induced Osteomalacia: A Retrospective Study.
Li X; Jiang Y; Huo L; Wu H; Liu Y; Jin J; Yu W; Lv W; Zhou L; Xia Y; Wang O; Li M; Xing X; Chi Y; Jiajue R; Cui L; Meng X; Xia W
J Bone Miner Res; 2020 Mar; 35(3):469-477. PubMed ID: 31643101
[TBL] [Abstract][Full Text] [Related]
42. Occipital bone and tumor-induced osteomalacia: a rare tumor site for an uncommon paraneoplastic syndrome.
Colangelo L; Sonato C; Cipriani C; Pepe J; Farinacci G; Palmisano B; Occhiuto M; Riminucci M; Corsi A; Minisola S
Arch Osteoporos; 2023 Jul; 18(1):94. PubMed ID: 37436671
[TBL] [Abstract][Full Text] [Related]
43. Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor-Induced Osteomalacia: Outcome of a Retrospective Surveillance.
Hidaka N; Koga M; Kimura S; Hoshino Y; Kato H; Kinoshita Y; Makita N; Nangaku M; Horiguchi K; Furukawa Y; Ohnaka K; Inagaki K; Nakagawa A; Suzuki A; Takeuchi Y; Fukumoto S; Nakatani F; Ito N
J Bone Miner Res; 2022 Aug; 37(8):1479-1488. PubMed ID: 35690913
[TBL] [Abstract][Full Text] [Related]
44. [Tumor-induced osteomalacia caused by an FGF23-secreting myopericytoma : Case report and literature review].
Muro Bushart N; Tharun L; Oheim R; Paech A; Kiene J
Orthopade; 2020 Jan; 49(1):1-9. PubMed ID: 30937490
[TBL] [Abstract][Full Text] [Related]
45. Tumor-induced osteomalacia.
Fukumoto S
Panminerva Med; 2024 Jun; 66(2):188-197. PubMed ID: 38127062
[TBL] [Abstract][Full Text] [Related]
46. [Tumor-induced Hypophosphatemic Osteomalacia Caused by a Chest Wall Tumor].
Kin Y; Ogawa H; Matsumoto G; Mitsui S; Matsumoto T; Nishioka Y; Sakai S; Kimura K; Shimizu N; Hokka D; Tanaka Y; Maniwa Y
Kyobu Geka; 2019 Aug; 72(8):570-573. PubMed ID: 31353346
[TBL] [Abstract][Full Text] [Related]
47. A case of oncogenic osteomalacia due to occult nasal sinus tumor.
Ray S; Chakraborty PP; Biswas K; Ghosh S; Mukhopadhyay S; Chowdhury S
Clin Cases Miner Bone Metab; 2015; 12(1):65-8. PubMed ID: 26136801
[TBL] [Abstract][Full Text] [Related]
48. Tumor-induced hypophosphatemic osteomalacia caused by a mesenchymal tumor of the mandible managed by a segmental mandibulectomy and microvascular reconstruction with a free fibula flap.
Acharya RP; Won AM; Moon BS; Flint JH; Roubaud MS; Williams MD; Hessel AC; Murphy WA; Chambers MS; Gagel RF
Head Neck; 2019 Jun; 41(6):E93-E98. PubMed ID: 30859653
[TBL] [Abstract][Full Text] [Related]
49. Oncogenic osteomalacia induced by a sinonasal tumour: case report and review.
Kabtouri H; Karmali R; Spinato L; Khamaktchian M; Bisschop P
B-ENT; 2014; 10(2):149-55. PubMed ID: 25090814
[TBL] [Abstract][Full Text] [Related]
50. The Right Leg that Troubled the Left Leg.
B S; V A
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116017
[TBL] [Abstract][Full Text] [Related]
51. Tumor-Induced Osteomalacia.
Florenzano P; Hartley IR; Jimenez M; Roszko K; Gafni RI; Collins MT
Calcif Tissue Int; 2021 Jan; 108(1):128-142. PubMed ID: 32504138
[TBL] [Abstract][Full Text] [Related]
52. Tumor-induced osteomalacia.
Florenzano P; Gafni RI; Collins MT
Bone Rep; 2017 Dec; 7():90-97. PubMed ID: 29021995
[TBL] [Abstract][Full Text] [Related]
53. Tumour-induced osteomalacia: the long road to diagnosis and recovery.
Vollmer S; Olsson K
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38697682
[TBL] [Abstract][Full Text] [Related]
54. Long-term use of burosumab for the treatment of tumor-induced osteomalacia.
Crotti C; Zucchi F; Alfieri C; Caporali R; Varenna M
Osteoporos Int; 2023 Jan; 34(1):201-206. PubMed ID: 35925260
[TBL] [Abstract][Full Text] [Related]
55. Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumption.
Hidaka N; Kato H; Koga M; Katsura M; Oyama Y; Kinoshita Y; Fukumoto S; Makita N; Nangaku M; Ito N
Bone Rep; 2021 Dec; 15():101144. PubMed ID: 34901334
[TBL] [Abstract][Full Text] [Related]
56. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases.
Feng J; Jiang Y; Wang O; Li M; Xing X; Huo L; Li F; Yu W; Zhong DR; Jin J; Liu Y; Qi F; Lv W; Zhou L; Meng XW; Xia WB
Endocr J; 2017 Jul; 64(7):675-683. PubMed ID: 28450684
[TBL] [Abstract][Full Text] [Related]
57. Tumor-induced osteomalacia: a case report.
Aligail K; Dave JA; Ross IL
J Med Case Rep; 2022 Jan; 16(1):22. PubMed ID: 35016725
[TBL] [Abstract][Full Text] [Related]
58. Neurofibromatosis type 1 associated with hypophosphatemic osteomalacia due to hypersecretion of fibroblast growth factor 23: a case report.
Obo T; Koriyama N; Tokito A; Ogiso K; Nishio Y
J Med Case Rep; 2020 May; 14(1):56. PubMed ID: 32384911
[TBL] [Abstract][Full Text] [Related]
59. Phosphaturic mesenchymal tumor-induced bilateral osteomalacia femoral neck fractures: a case report.
Zhang Y; Hu M; Guo C; Yang X; Xiang S; Xu H
Front Endocrinol (Lausanne); 2024; 15():1373794. PubMed ID: 38689735
[TBL] [Abstract][Full Text] [Related]
60. Oncogenic osteomalacia due to phosphaturic mesenchymal tumour in the upper thoracic spine.
Garg B; Mehta N; Goyal A; Khadgawat R
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33328210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
